List of Aspen Process Pulse Customers
Bedford, 1730, MA,
United States
Since 2010, our global team of researchers has been studying Aspen Process Pulse customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Aspen Process Pulse for Asset Performance Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Aspen Process Pulse for Asset Performance Management include: Thermo Fisher Scientific, a United States based Life Sciences organisation with 125000 employees and revenues of $42.88 billion, Ferring Pharmaceuticals, a Switzerland based Life Sciences organisation with 6000 employees and revenues of $2.28 billion, GSK United Kingdom, a United Kingdom based Life Sciences organisation with 1400 employees and revenues of $804.0 million and many others.
Contact us if you need a completed and verified list of companies using Aspen Process Pulse, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Aspen Process Pulse customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Ferring Pharmaceuticals | Life Sciences | 6000 | $2.3B | Switzerland | AspenTech | Aspen Process Pulse | Asset Performance Management | 2021 | n/a |
In 2021, Ferring Pharmaceuticals deployed Aspen Process Pulse as part of a manufacturing and quality-control (PAT) implementation at its Swiss pharmaceutical operations. The deployment used Aspen Process Pulse alongside Aspen Unscrambler to prototype continuous manufacturing enabled by PAT driven closed-loop control.
The implementation centered on multivariate analytics and chemometrics, model development and operationalized model scoring within Aspen Process Pulse and Aspen Unscrambler. Configuration focused on PAT-enabled closed-loop control workflows and real-time release testing, consolidating analytics, model management and control logic to support end to end process monitoring and automated decisioning.
Operational integration tied the PAT analytics layer into plant control loops and online PAT instrumentation to enable RTRT and closed-loop responses, supporting manufacturing and quality control functions on active production lines in Switzerland. The scope emphasized prototyping continuous manufacturing rather than a broad enterprise rollout, keeping implementation boundaries at manufacturing and QC operations.
Governance changes included establishing model validation and operational monitoring processes for chemometric models, and adjusting quality workflows to accommodate real-time release testing. The program reduced manufacturing footprint, enabled real-time release testing and improved production agility, with an approximate 25% reduction in cost of goods sold as reported during the prototype phase.
|
 |
GSK United Kingdom | Life Sciences | 1400 | $804M | United Kingdom | AspenTech | Aspen Process Pulse | Asset Performance Management | 2021 | n/a |
In 2021, GSK United Kingdom implemented Aspen Process Pulse together with Aspen Unscrambler to monitor bioreactor pH and detect probe faults in a manufacturing/quality (process/PAT) deployment. The implementation targeted bioprocess monitoring within pharmaceutical manufacturing sites in the United Kingdom, focusing on real time process analytical technology capabilities to protect batch quality.
Aspen Process Pulse was configured to run continuous process monitoring and fault detection workflows, applying PAT analytics for pH sensor validation and early anomaly identification. Configuration emphasized probe health diagnostics and automated flagging of out‑of‑range signals, enabling operational teams to intervene before batch compromise.
The deployment integrated Aspen Process Pulse with Aspen Unscrambler for complementary multivariate analysis and pattern recognition, consolidating sensor telemetry and advanced analytics for bioreactor pH control. Operational coverage spanned manufacturing and quality functions, with system outputs feeding shift operations and quality review processes to support batch disposition decisions.
Governance centered on process monitoring and fault remediation workflows, with defined escalation for probe faults and batch hold decisions. The implementation delivered early fault detection and reduced wasted batches, preventing an estimated $5 million loss of biopharma drug substance.
|
 |
Thermo Fisher Scientific | Life Sciences | 125000 | $42.9B | United States | AspenTech | Aspen Process Pulse | Asset Performance Management | 2021 | n/a |
In 2021, Thermo Fisher Scientific deployed Aspen Process Pulse in a Manufacturing/Quality (PAT) implementation to enable continuous manufacturing of solid-dose products within its United States pharmaceutical operations. The deployment tied Aspen Process Pulse directly to production workflows to use real-time analytical outputs as control inputs and to keep production continuously in-spec while improving productivity.
Aspen Process Pulse was configured to capture real-time process and PAT measurements, translate those outputs into actionable control signals, and trigger automated interventions in the process control system to create closed-loop responses to off-spec conditions. The implementation emphasized process analytical technology workflows, real-time monitoring, and feedback control to sustain product quality across continuous production runs.
Integration work focused on routing Aspen Process Pulse outputs into the plant automation layer so manufacturing and quality functions could act on the same real-time signals, with operational governance centered on control logic ownership and PAT data stewardship by production and QA teams. The project delivered real-time control, sustained product quality, and reduced total cost of supply while enabling higher productivity on continuous solid-dose manufacturing lines.
|
Buyer Intent: Companies Evaluating Aspen Process Pulse
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||